Добавил:
shahzodbeknormurodov27@gmail.com Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Practical Urology ( PDFDrive ).pdf
Скачиваний:
12
Добавлен:
27.08.2022
Размер:
25.91 Mб
Скачать

12

Molecular Biology for Urologists

Peter E. Clark

Introduction

The last several decades have seen an explosion of science and technology across all walks of life, and medicine is no exception. Improvements in engineering, optics, laser technology, pharmacology,and molecular biology have radically changed how we take care of patients on a daily basis. The development of the “Targeted Therapies” for advanced renal cell carcinoma (RCC) is just an one example of how discoveries in the basic biology of a disease have contributed to the development of novel therapeutics,thus markedly altering the standard of care for this disease. The field of urology has traditionally been at the forefront of these discoveries, as evidenced by the Nobel Prize winning work of Huggins and Hodges during the last century. As we move through the twenty-first century, a fundamental understanding of molecular biology will be increasingly important to understand the basis for the therapies we prescribe. The purpose of this chapter is to introduce the practicing urologist to the basics of molecular biology and its relevance to our field. It is impossible to relate all of molecular biology, in all its rich, intricate detail, in this short chapter. Therefore, the goal will be to illustrate some basic principles utilizing one of the most prominent examples relevant to urology today.The approach will be to introduce the basic principles of molecular biology using the biology of RCC as an example. The implications and how modern, targeted therapies fit into this biology will be emphasized.

The hope is that by learning the basic principles as they relate to one disease, the interested reader can go on to learn about the relevant pathways in other diseases as well using the same principles. Since it is impossible to give proper attention to every pathway and every disease, and the field changes so rapidly (indeed the pace of change is accelerating), the interested reader is encouraged to pursue specific interests in other pathways/disease via the many recent reviews cited throughout this chapter and elsewhere to explore these concepts in greater depth. Note that many of the terms introduced in this chapter (those that are in bold type and underlined) are listed in Table 12.1 with a brief definition.

Tumor Suppressor Genes

and VHL

One of the basic principles of molecular biology as it relates to the development of neoplasms (oncogenesis) is the concept of a tumor suppressor gene. These genes are important in regulating a variety of cellular processes, but their unifying theme is that when these genes’ (or their protein) function is lost in a cell, that cell becomes prone to malignant transformation. This fundamental concept grew out of the development of the tumor suppressor gene theory and the two-hit hypothesis as described by Knudson.1,2 Under this hypothesis, both copies of a tumor suppressor gene must be disabled in

C.R. Chapple and W.D. Steers (eds.), Practical Urology: Essential Principles and Practice,

161

DOI: 10.1007/978-1-84882-034-0_12, © Springer-Verlag London Limited 2011

 

 

 

 

162

 

 

 

 

 

 

 

Practical Urology: EssEntial PrinciPlEs and PracticE

Table 12.1. important definitions and concepts in molecular biology

Term

Section

Definition

tumor suppressor gene

a

a gene encoding a protein which when lost tends to result in the formation of a

 

 

 

neoplasm

genome

a

all the genes found within a given organism

somatic cell

a

the cells within a multicellular organism that do not produce gametes (oocyte

 

 

 

or sperm).these represent the vast majority of cells in an organism

germ line mutations

a

a permanent, heritable change in the dna sequence within the genome of a

 

 

 

gamete (oocyte or sperm). as a result, it is present in every cell of any

 

 

 

organism which develops from that cell

chromosome

a

the structure within the cell nucleus that stores the dna in linear strands

 

 

 

associated with a variety of proteins such as histones

genetic changes

B

direct mutations or alterations in the dna sequence that are passed on from

 

 

 

parent to progeny cells

Epigenetic changes

B

Heritable changes in the expression of genes which do not involve a direct dna

 

 

 

mutation. an example is dna methylation

codon

B

a sequence of three adjacent nucleotides that codes for a particular amino acid.

 

 

 

the sequence of these successive codons specifies the amino acid sequence

 

 

 

of the resulting protein

Frame shift mutation

B

a mutation (or change in dna) in which nucleotides are inserted or deleted

 

 

 

such that the downstream sequence of codons is scrambled. since dna is

 

 

 

read three nucleotides at a time (see codon above) a shift in the nucleotide

 

 

 

sequence puts the entire remaining sequence out of frame, resulting in a

 

 

 

scrambled and nonfunctional protein

nonsense mutation

B

a mutation (or change in dna) in which an early or premature stop codon is

 

 

 

created, resulting in a truncated protein that is typically nonfunctional.

Missense mutation

B

a mutation (or change in dna) in which single nucleotide within a codon is

 

 

 

changed resulting in a single amino acid change in a protein.this may or

 

 

 

may not result in altered function

dna methylation

B

Modification of dna in which a methyl group (cH3) is added to a cytosine that

 

 

 

immediately precedes a quanine (cpg island).this is carried out by enzymes

 

 

 

called dna methyl transferases (dnMt)

Promoter

B

the site in the dna associated with a particular gene where the proteins

 

 

 

responsible for transcription bind to initiate mrna expression. as a result,

 

 

 

this site is where the expression of that particular gene is controlled

response element

c

the dna nucleotide sequence in the promoter of a gene that is recognized by

 

 

 

a regulatory protein that controls transcription, such as the HiFa/b

 

 

 

heterodimer. Binding of the regulatory protein to its response element within

 

 

 

a particular gene will either upor downregulate expression of that gene

Messenger rna (mrna)

c

a single stranded rna molecule, coded for by the dna of a gene, which specifies

 

 

 

the subsequent amino acid sequence of a protein during protein synthesis

transcription

c

the process by which the genetic code in dna is transcribed into a complemen-

 

 

 

tary, single stranded mrna molecule for subsequent protein synthesis

translation

c

the process whereby the genetic code stored in the transcribed mrna molecule

 

 

 

is now translated into a sequence of amino acids to form a protein.this is

 

 

 

accomplished by the cooperative work of the ribosomes and trna that is

 

 

 

associated with specific amino acids

163

MolEcUlar Biology For Urologists

Table 12.1. (continued)

 

 

Term

Section

Definition

oncogene

c

a gene that is mutated or overexpressed in a cell, allowing it to become

 

 

neoplastic or malignant

Polymerase chain

c

a technique to significantly amplify a specific stretch of dna using a set of dna

reaction (Pcr)

 

primers designed to specify an area of interest

rt-Pcr

c

a variation of Pcr in which mrna is reverse transcribed into dna and then Pcr

 

 

is done on a gene of interest.this allows the scientist to measure gene

 

 

expression at the mrna level

genomics

c

a large-scale, rapid screen of gene expression across the entirety of the cell’s

 

 

dna, that is, its genome

Proteomics

c

a large-scale, rapid screen of the level of all the proteins within a cell at a given

 

 

time

angiogenesis

d

the process by which new blood vessels are formed

ligand

d

a molecule, typically a soluble one such as a hormone, which binds to another

 

 

molecule to initiate a subsequent downstream effect

receptor

d

a molecule within or on the surface of a cell that when it binds its specific ligand

 

 

(see above) it results in specific,downstream effects important to cellular function.

Kinase

d

a frequently used abbreviation for a phosphokinase.these are enzymes which

 

 

transfer a phosphate group from atP to another molecule

cytoplasm

d

the portion of a eukaryotic cell that lies between the outer cellular surface

 

 

membrane and the inner nucleus. it houses much of the cell’s physiologic

 

 

machinery and organelles, such as the mitochondria, ribosomes, golgi

 

 

apparatus, and endoplasmic reticulum

nucleus

d

the large organelle that houses the genomic dna in eukaryotic cells within

 

 

chromosomes

Phosphorylation

d

the process whereby phosphate bonds are created between two substrates. in

 

 

cells this is accomplished usually by kinases

tyrosine kinase

d

an enzyme that transfers a phosphate group from atP to a tyrosine residue,

 

 

either within its own structure or another molecule

targeted therapy

E

a form of therapy that is designed to specifically target molecules important to

 

 

the growth of cancer cells, rather than just target rapidly dividing cells such as

 

 

cytotoxic therapy (i.e., traditional chemotherapy). Examples include

 

 

antibodies to specific molecules and small molecule kinase inhibitors

Monoclonal antibody

E

an antibody that can be produced in large quantities in a pure form from a

 

 

single cell clone. Each antibody molecule is identical with respect to its

 

 

structure and specificity for a particular target (termed an antigen)

tyrosine kinase inhibitor

F

a small molecule that interferes with the tyrosine kinase activity of enzymes in

 

 

cells.this is a prototypical example of a targeted therapy

cell cycle

g

the regulated sequence by which cells undergo the process of growth and cell

 

 

division/replication

apoptosis

 

also termed programmed cell death, it is the active, regulated process by which

 

 

cells die in response to external or internal stimuli

Heterodimer

 

the association between two different proteins to form a complex. an example is the

 

 

association between HiFaand HiFbin response to hypoxia or loss of VHl protein

Homodimer

 

the association between two identical proteins to form a complex. an example

 

 

is the association between two androgen receptor molecules within a cell

 

 

164

 

 

 

 

 

Practical Urology: EssEntial PrinciPlEs and PracticE

order for a cancer to develop. In a sporadic, non-

What followed was based on the recognition

inherited form of cancer, this means that for any

that these sporadic clear cell RCCs were also

given cell in the body, a mutation is needed in

seen in von Hippel-Lindau disease and the

both copies of the same gene. This is because

abnormality on chromosome 3p fit the profile of

any mutation or change in the genome would be

a putative tumor suppressor gene. In a series of

in a somatic cell, and so, only that particular cell

elegant and groundbreaking studies of multiple

and its progeny would have that change, whereas

different families with von Hippel-Lindau dis-

the remaining cells in the body would not. It

ease, the localization of the VHL gene was

would be a rare event that each copy of a par-

mapped to a relatively small region on chromo-

ticular gene would acquire a mutation in the

some 3p,1820, which was then followed by the

same cell; so in sporadic, nonfamilial cancers,

identification of the VHL gene in a seminal arti-

the tumors generally occur later in life and are

cle by Latif et al. in 1993.21 Since that time, it has

usually unifocal. On the other hand, in inherited

been demonstrated that the majority of sporadic

familial tumor syndromes, there is a germ line

clear cell RCC tumors harbor aberrations of

mutation in one tumor suppressor gene. Thus,

VHL, strongly suggesting that the same gene

every cell in the body has inherited a nonfunc-

was responsible for both the inherited and non-

tional copy of the gene (the first hit). As a

inherited forms of the disease.1,2,2226 Indeed,

consequence, now it only takes one additional

even in cases where mutations of VHL were not

mutation of the same gene (the second hit) in

identified, most often other aberrations were

one cell in order for a cancer to develop. Since

noted such as abnormal hypermethylation of

every cell already has the first hit, having a sec-

the promoter region of VHL, leading to low or

ond hit would be more common. Patients suffer-

absent protein levels (see below).27

ing from such inherited tumor syndromes

Since the discovery of VHL, its role in the nor-

would, therefore, develop cancers in the affected

mal function of the cell and how it can act as a

organs at a younger age and tend to have multi-

tumor suppressor gene has been carefully stud-

focal disease. The basic tenets of this hypothesis

ied.The principles illustrated here are applicable

were developed in the 1980s for familial tumor

to a host of other disease processes and serve as

syndromes such as retinoblastoma and the Rb

an excellent example of how the discoveries at

gene and neurofibromatosis and the NF-1 and

the bench have been translated to the bedside in

NF-2 genes.37 In urology, the classic example of

the form of new targeted agents for advanced

this is von Hippel-Lindau disease, the VHL gene,

RCC. It is instructive, therefore, to describe this

and the development of clear cell RCC.

in some detail, though the interested reader is

The discovery of the VHL gene and its rele-

encouraged to read any one of the many in-

vance to clear cell RCC grew at first from the

depth reviews on this topic.

observation that the RCC in von Hippel-Lindau

 

disease was identical to its sporadic, nonfamilial

Inherited Changes in Cancer Cells

counterpart in every respect except it occurred

earlier in life and tended to be multifocal. It

 

therefore fit the profile of a familial tumor syn-

It is worth pausing for a moment to review vari-

drome characterized by the loss/mutation of a

ous ways in which a gene, such as VHL, can

tumor suppressor gene. Careful studies of three

become aberrantly regulated. A critical element

different families (kindreds) with a familial ten-

for all of these mechanisms is that they can be

dency toward the development of clear cell RCC

inherited or passed on to any progeny cells.

had consistently showed aberrations of the short

Thus, once a “parent” or originating cancer cell

arm of chromosome 3 (termed 3p).810 This

acquires one of these changes, those changes are

was followed by a series of studies of clear cell

passed on to all its progeny resulting in the

RCC tumors and cell lines that also showed

growth of a tumor. The two fundamental forms

abnormalities of chromosome 3p as a unifying

of such changes are genetic changes, such as

theme.1115 The changes noted in chromosome 3

direct mutations of DNA,and epigenetic changes,

were not present in normal tissues in these spo-

inherited alterations in how genes are expressed

radic clear cell RCC tumors and were not pres-

(such as DNA methylation). Both of these mech-

ent in other histologic RCC variants (such as

anisms can be demonstrated in the VHL gene

papillary RCC).16,17

and clear cell RCC.

165

MolEcUlar Biology For Urologists

Genetic changes (mutations of the DNA in the

them (de-acetylated via enzymes called histone

genome) are inherited from one cell and passed

de-acetylases or HDACs) or methyl groups

on to all its progeny. If that cell is a gamete, such

added (methylated via enzymes called histone

as an egg or sperm, then this mutation will be

methyltransferases, HMTs). In both cases, these

found in every cell in the new organism. These

can cause gene expression to be silenced.Perhaps

are the types of mutations found in familial

the most intensely studies form of epigenetic

tumor syndromes such as von Hippel-Lindau

change as it relates to cancer is the silencing of

Disease. If a mutation occurs in a non-gamete

gene expression via DNA methylation. This

cell (i.e., any cell after conception), then this

involves the covalent bonding of a methyl group

somatic mutation is passed on only to that cell’s

to a cytosine in areas where there is a cytosine

progeny. Furthermore, such a somatic mutation

immediately followed by a guanine, a sequence

will not be passed on from generation to genera-

known as a CpG island. This is carried out by a

tion. These are the mutations found in sporadic

class of enzymes called DNA methyltransferases

cancers. The types of mutations that can occur in

(DNMTs). When these CpG islands are methy-

the DNA include insertions or deletions of small

lated in the promoter of a gene, the gene’s expres-

or large portions of the DNA. Since every three

sion is often shut down. This mechanism is

DNA nucleotides represents one codon (coding

relevant to clear cell renal cell carcinoma, in that

element for one amino acid), if the insertion or

a significant fraction of sporadic RCCs have

deletion occurs in a multiple of three, the overall

been shown to lose VHL protein through DNA

protein function may or may not be disrupted

methylation and gene silencing, an epigenetic

depending on what amino acid(s) is inserted/

change, rather than by a mutation.27 There is

deleted. If the number of nucleotides inserted/

ongoing and intensive interest in the therapeutic

deleted is not a multiple of three, then the entire

potential of HDAC and DNMT inhibitors across

sequence of nucleotide codons and resulting

a variety of tumor types, though their direct

amino acids will be altered resulting in a frame

clinical utility in RCC remains to proven.

shift mutation. This will, in effect, result in a

 

scrambled series of amino acids and a nonfunc-

The Tumor Suppressor VHL,

tional protein. Roughly, half the VHL mutations

found in sporadic clear RCC are of this type.22

Oncogene HIF, and Gene

 

This will result in a completely nonfunctional

Regulation

protein. In some cases, the nucleotide may be

mutated in a way that places a premature stop

 

codon, so a portion of the protein is truncated.

In a normal cell, the VHL protein acts predomi-

These are referred to as nonsense mutations. In

nantly to regulate the cell’s response to the local

other cases, one nucleotide is mutated/changed

availability of oxygen.3338 When local oxygen

such that only one amino acid is altered. This is

levels are normal, there is another regulatory

termed a missense mutation and represents the

protein, termed hypoxia inducible factor alpha

majority of the remaining VHL mutations in

(HIFa), which is hydroxylated permitting it to

sporadic, clear cell RCCs.22 A more in-depth

bind to the VHL protein (see Fig. 12.1).39,40 The

analysis of the specific VHL mutations and their

VHL protein is actually part of an enzyme com-

potential relationship to disease biology has

plex (called an E3 ligase) that joins a series of

been reviewed previously.28,29

molecules to HIFa called ubiquitin, which in

The expression of genes can also be altered

turn marks HIFa for degradation.4146 In the

via mechanisms that do not involve a mutation

normal circumstance, then, HIFa levels are low

in DNA. If these alterations are heritable, then

in the cell. During hypoxia when oxygen levels

these are termed epigenetic changes.3032 The

in the cell are low, HIFa is not hydroxylated, so

ability to silence genes is critical to the normal

it does not bind to VHL protein, and conse-

development of an organism. There are a num-

quently is not degraded. The levels of HIFa in

ber of mechanisms by which this can be accom-

the cell rise, allowing it to bind with a similar

plished. This includes modifications of the

molecule, HIF-b, that exists at high levels in the

proteins that are involved in packaging DNA

cell at all times (see Fig. 12.2). This complex can

within the nucleus of cells called histones. These

then bind to specific regions in the cell’s nuclear

histones can have acetyl groups removed from

DNA called hypoxia response elements (HRE).

166

Practical Urology: EssEntial PrinciPlEs and PracticE

Figure 12.1. normal regulation of HiFa: under normal conditions, with normal levels of tissue oxygenation, HiFais hydroxylated through the action of enzymes termed prolylhyroxylases.this hydroxylation allows it to associate with an E3 ligase complex that includes the VHl protein.the VHl protein in particular is critical to this association.the E3 ligase then enzymatically tags HiFa with a series of molecules (called ubiquitin).this ubiquitination then marks HiFato be recognized and degraded by the proteasomal complex within the cell. HIFa Hypoxia inducible Factor alpha, VHL von Hippel lindau, Ub ubiquitin, HRE hypoxia response element.

 

HIFα

p

Cytoplasm

 

p

 

 

O2

Prolyl-hydroxylases

 

 

 

 

HIFα

p

 

 

p

OH

 

VHL

 

OH

 

 

 

 

E3 ligase

 

 

 

 

HIFα

p

 

 

p

OH

 

 

 

OH VHL

 

Ub

 

E3 ligase

 

Ub

 

 

HRE

Ub

 

 

 

 

Ub

 

 

 

HIFα

p

 

 

p

OH

Nucleus

 

 

OH

 

 

 

Proteasome

These HREs are found in the regulator region, called the promoter, of genes important in the cell’s response to hypoxia. When a transcriptional regulator, such as the HIFa/b complex, binds to the response element (HRE) in the promoter of a gene, the transcriptional machinery of the cell is turned on and messenger RNA (mRNA) specific for that gene is produced in a process called gene transcription (see Fig. 12.3). These mRNA molecules then translocate to the cell’s cytoplasm where the code embedded in the mRNA is translated into a series of amino acids to generate the specific protein corresponding to that gene (gene translation). In the case of HIF and hypoxia, these correspond to a variety of genes that are critical to the cell’s response to hypoxia. These include vascular endothelial growth factor (VEGF), platelet derived growth factor (PDGF), transforming growth factor alpha (TGFa), carbonic anhydrase IX (CA-IX), erythropoietin, glucose transporter 1 (GLUT-1), and others. The VHLHIF axis serves as a good example, then, of a tumor suppressor (VHL) regulating an oncogene (HIFa) that in turn transcriptionally regulates a series of other genes that are important to normal cellular function.

In the setting of clear cell RCC, the normal balance in the cell is upset. When the VHL protein either cannot function or is abnormally low/absent in the cell, then no matter the oxygen levels in the cell, HIFa is always at a high level since it cannot be marked for degradation (see Fig. 12.2). Thus,VHL protein is functioning as a tumor suppressor. High levels of HIFa in turn mean the HIFa/b complex will interact with the HREs in the nucleus and the genes normally regulated by HIF will be transcribed and translated at an abnormally high rate (see Fig. 12.3). It is this upregulation of genes such as VEGF, PDGF, and TGFa that is thought to lead to clear cell RCC. Therefore, HIFais acting as an oncogene.

It is worth pausing for a moment to review a number of general techniques and concepts that are important in the context of molecular biology. These concepts have been part of some of the studies discussed in this chapter and are an integral part of many, as yet unpublished work that is still ongoing in many centers across the world. These involve different ways of interrogating the genetic makeup of tissues (such as tumors) and how these tissues express different proteins that regulate their function.

167

MolEcUlar Biology For Urologists

HIFα p Cytoplasm

p

 

O2

 

 

 

 

 

Prolyl-hydroxylases

 

 

HIFα

 

 

 

HIFβ

 

 

 

 

 

 

 

OH

 

 

 

 

 

OH

 

 

 

 

 

 

 

HIFβ

E3 ligase

 

 

 

 

HIFα p

 

HIFα

 

 

 

 

 

 

OH

 

 

 

 

 

 

p

OH

 

OH

 

 

 

 

 

OH

 

 

 

 

 

HIFα

p

 

 

HRE

 

p

OH

HIFα

p

 

 

OH

 

 

 

p

OH

HIFα

 

 

 

p

 

 

 

OH

 

 

 

 

 

 

p OH

 

 

 

Nucleus

 

OH

HIFα

 

 

 

 

p

HIFβ

 

 

 

 

 

 

p

OH

 

 

 

 

 

OH

 

Figure 12.2. accumulation of HiFa: under conditions of hypoxia, prolyl-hydroxylases cannot hydroxylate HiFa and so it will not bind to the VHl-E3 ligase complex. alternatively (as depicted here), if VHl protein is mutated, nonfunctional, or not present the VHl-E3 ligase cannot bind to HiFa. in either case, HiFais not ubiquitinated, and so is not degraded by the proteasome. it accumulates within the cell and associates with the constitutively present related molecule, HiFb. this heterodimer now translocates to the nucleus where it binds to specific regions

For example, one of the major advances in the study of biology has been the technique of the polymerase chain reaction (PCR). This is essentially a technique to significantly amplify a specific stretch of DNA using a set of DNA primers that the investigator can design to home in on an area of interest. The primers specify exactly what stretch of DNA is amplified. This technique has revolutionized the entire field of gene discovery and cloning. A variation of this can now be done whereby the mRNA in a cell can be reversely transcribed into DNA, and PCR then done on this, so called RT-PCR. This technique can now allow biologists to measure the relative expression levels of different genes in cells to see which are upor downregulated. Further refinements using these basic principles have

(hypoxia response elements or HrE’s) in the promoters of genes upregulated by HiF. the binding of the HiFa-HiFb heterodimer to this promoter region at the HrE turns on gene transcription. note that if VHl is absent or not functional, then no matter what the oxygenation level, HiFa cannot be recognized by the E3 ligase complex and is not degraded. HiFa accumulates in the cell even in the absence of hypoxia. HIFa Hypoxia inducible Factor alpha, HIFb Hypoxia inducible Factor beta, VHL von Hippel lindau, HRE hypoxia response element.

allowed such studies to be done on a mass scale using “gene chips” that now allow for measurement of thousands of genes at once. This large scale, rapid screen of gene expression across the entirety of the cell’s DNA,that is,its genome, is referred to as genomics. Other techniques can now screen the entirety of a cell’s protein mix using a variety of techniques generally referred to as proteomics. Indeed, the number of “–omics” has continued to expand including metabolomics, lipidomics, and others. Mass scale screenings of gene and protein expression is allowing investigators to create a signature for individual patients and tumors (or other diseased tissue). It is these approaches that hold the promise of “individualized” medicine for the future.